کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
4137935 | 1272114 | 2012 | 15 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Recomendaciones para la determinación de biomarcadores en el carcinoma de pulmón no microcÃtico avanzado. Consenso nacional de la Sociedad Española de AnatomÃa Patológica y de la Sociedad Española de OncologÃa Médica
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
آسیبشناسی و فناوری پزشکی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Although this field of research is constantly evolving, with data available at the present time, this panel of experts recommends that all patients with advanced NSCLC of non-squamous cell subtype, or non-smokers regardless of the histological subtype, should be tested for EGFR gene mutations within a maximum of 7 days subsequent to the histopathological confirmation of the diagnosis. Participating laboratories must comply with external quality controls. However, at present, ALK gene rearrangements should only be tested in the context of a clinical trial, although the promising results obtained to date would suggest that its routine testing in patients with no EGFR mutations will be justified in the near future. Lastly, routine testing for other molecular abnormalities is not considered necessary in current clinical practice.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Revista Española de PatologÃa - Volume 45, Issue 1, JanuaryâMarch 2012, Pages 14-28
Journal: Revista Española de PatologÃa - Volume 45, Issue 1, JanuaryâMarch 2012, Pages 14-28
نویسندگان
José Javier Gómez, Javier de Castro, Ángel Concha, Enriqueta Felip, Dolores Isla, Fernando López-RÃos, Luis Paz-Ares, José RamÃrez, Julián Sanz, Pilar Garrido,